ABBV stock, with 24% returns since the beginning of 2024, has marginally underperformed the S&P 500 index, up 27%. An ...

like methotrexate or cyclosporine and biologic drugs like Humira (adalimumab) or Enbrel (etanercept) are generally reserved for cases that eventually become plaque psoriasis. Even then ...

Humira’s success is down to its incredible versatility – an anti-TNF drug, it is approved in a range of inflammatory diseases, including rheumatoid arthritis, plaque psoriasis and Crohn’s ...

Study findings released at this week's European Academy of Dermatology and Venereology (EADV) conference showed patients with moderate to severe plaque psoriasis, who had used Humira but had not ...

and adalimumab (Humira; Trudexa/Abbott), which are routinely used to treat rheumatoid arthritis, as well as Crohn's disease and plaque psoriasis; the human epidermal growth factor receptor 2 (HER2 ...

MDedge News, October 24, 2023 Alert FDA Approves Bimekizumab for Plaque Psoriasis in Adults Bimekizumab ... 2023 Alert FDA OKs Ninth Humira Biosimilar, With Interchangeability The drug, adalimumab ...